Drug pull out
two Indian pharmaceutical companies, including pharma major Ranbaxy, have voluntarily pulled their anti- aids drugs out of the World Health Organization's (who) " prequalification' list. While Ranbaxy withdrew its seven remaining drugs on the list, Hyderabad-based Hetero Drugs withdrew all its six drugs on it. The reason cited was flaws in laboratory tests proving their effectiveness. Earlier this year, the who had removed three anti- aids drugs of Ranbaxy and two of another Indian firm, cipla, from the list after detecting similar discrepancies during inspections (see
Related Content
- Why seriously affected clinical trial patients not compensated? Supreme Court asks
- Cosmetics Horror
- India State of the Environment Report : The Monthly Overview, September 2013
- Pharma cos adopt tough ethical norms
- Health Secretary should monitor drug trials: SC
- SC flays Centre, MP for stance on illegal drug trials